StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Warrants

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jun 20, 2023 4:32pm

92 Views

Post# 35506030

RE:RE:Warrants

Nailbiter2 wrote:
A number of shareholders have asked if thy could extend the expiration date of the warrants and also reduce the exercise price of the warrants. Generally, shareholders obtain warrants as part of a private placement.

They have extended the expiration date on some warrants earlier this year. However, for the ones coming up this was the best way to manage it and also allow individuals to exercise their warrants rather than have them just expire.

It is a time consuming process to get permission to change any aspect of the warrants and you will see in the press release that they were unable to make any changes to the listed warrants.

This is a good thing as there are shareholders who will exercise their warrants rather than lose them and that will put money into StageZero. The press release was put out as part of the regulatory requirements when dealing with warrants.

"This is a good thing as there are shareholders who will exercise their warrants rather than lose them and that will put money into StageZero."
Check my earlier post; at 6.5 cents exercise price and best warrant price of .5 cents you would be paying almost double the current share price. In what universe would that make sense?

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland